These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32462388)

  • 1. Application of the p9NORM correction method to timed neuropsychological tests in Parkinson's disease and multiple system atrophy.
    Costabile T; Pane C; Aurisicchio L; Salvati A; Lieto M; Peluso S; Reia A; De Lucia N; De Rosa A; Filla A; De Michele G; Saccà F
    Neurol Sci; 2020 Dec; 41(12):3633-3641. PubMed ID: 32462388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normalization of timed neuropsychological tests with the PATA rate and nine-hole pegboard tests.
    Saccà F; Costabile T; Abate F; Liguori A; Paciello F; Pane C; De Rosa A; Manganelli F; De Michele G; Filla A
    J Neuropsychol; 2018 Sep; 12(3):471-483. PubMed ID: 28477351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new device-aided cognitive function test, User eXperience-Trail Making Test (UX-TMT), sensitively detects neuropsychological performance in patients with dementia and Parkinson's disease.
    Kokubo N; Yokoi Y; Saitoh Y; Murata M; Maruo K; Takebayashi Y; Shinmei I; Yoshimoto S; Horikoshi M
    BMC Psychiatry; 2018 Jul; 18(1):220. PubMed ID: 29976167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apraxia in Parkinson's disease and multiple system atrophy.
    Uluduz D; Ertürk O; Kenangil G; Ozekmekçi S; Ertan S; Apaydin H; Erginöz E
    Eur J Neurol; 2010 Mar; 17(3):413-8. PubMed ID: 20050896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease.
    Fiorenzato E; Antonini A; Camparini V; Weis L; Semenza C; Biundo R
    J Neural Transm (Vienna); 2019 Nov; 126(11):1437-1445. PubMed ID: 31432258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
    Fiorenzato E; Weis L; Falup-Pecurariu C; Diaconu S; Siri C; Reali E; Pezzoli G; Bisiacchi P; Antonini A; Biundo R
    J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive profiling in relation to short latency afferent inhibition of frontal cortex in multiple system atrophy.
    Celebi O; Temuçin ÇM; Elibol B; Saka E
    Parkinsonism Relat Disord; 2014 Jun; 20(6):632-6. PubMed ID: 24698055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and metabolic correlates of neuropsychological profiles in multiple system atrophy and Parkinson's disease.
    Kübler D; Kobylecki C; McDonald KR; Anton-Rodriguez JM; Herholz K; Carter SF; Hinz R; Thompson JC; Al-Fatly B; Gerhard A
    Parkinsonism Relat Disord; 2023 Feb; 107():105277. PubMed ID: 36621156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The language profile in multiple system atrophy: an exploratory study.
    Cuoco S; Picillo M; Carotenuto I; Erro R; Catricalà E; Cappa S; Pellecchia MT; Barone P
    J Neural Transm (Vienna); 2021 Aug; 128(8):1195-1203. PubMed ID: 34216238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trail Making Test Could Predict Impairment in Cognitive Domains in Patients with Multiple Sclerosis: A Study of Diagnostic Accuracy.
    Kabiri S; Jameie M; Balali P; Adib Moradi S; Sanjari Moghaddam H; Aghamollaii V; Harirchian MH
    Arch Clin Neuropsychol; 2023 Jan; 38(1):37-48. PubMed ID: 35901460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychological and clinical heterogeneity of cognitive impairment in patients with multiple system atrophy.
    Barcelos LB; Saad F; Giacominelli C; Saba RA; de Carvalho Aguiar PM; Silva SMA; Borges V; Bertolucci PHF; Ferraz HB
    Clin Neurol Neurosurg; 2018 Jan; 164():121-126. PubMed ID: 29223069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
    J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of auditory and vestibular dysfunction in Parkinson's disease and Multiple System Atrophy.
    Scarpa A; Cassandro C; Vitale C; Ralli M; Policastro A; Barone P; Cassandro E; Pellecchia MT
    Parkinsonism Relat Disord; 2020 Feb; 71():51-57. PubMed ID: 32032926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinimetric validity of the Trail Making Test Czech version in Parkinson's disease and normative data for older adults.
    Bezdicek O; Stepankova H; Axelrod BN; Nikolai T; Sulc Z; Jech R; Růžička E; Kopecek M
    Clin Neuropsychol; 2017; 31(sup1):42-60. PubMed ID: 28534428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of parkinsonian syndromes according to differences in executive functions.
    Lange KW; Tucha O; Alders GL; Preier M; Csoti I; Merz B; Mark G; Herting B; Fornadi F; Reichmann H; Vieregge P; Reiners K; Becker G; Naumann M
    J Neural Transm (Vienna); 2003 Sep; 110(9):983-95. PubMed ID: 12938023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of smooth pursuit eye movement deficits in multiple system atrophy and Parkinson's disease.
    Pinkhardt EH; Kassubek J; Süssmuth S; Ludolph AC; Becker W; Jürgens R
    J Neurol; 2009 Sep; 256(9):1438-46. PubMed ID: 19363627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognition in multiple system atrophy: neuropsychological profile and interaction with mood.
    Balas M; Balash Y; Giladi N; Gurevich T
    J Neural Transm (Vienna); 2010 Mar; 117(3):369-75. PubMed ID: 20091064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy.
    Chung EJ; Lee WY; Yoon WT; Kim BJ; Lee GH
    Mov Disord; 2009 Aug; 24(11):1650-5. PubMed ID: 19514077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Symbol-Digit Modalities Test in Mild Cognitive Impairment: Evidence from Parkinson's Disease Patients.
    Pascoe M; Alamri Y; Dalrymple-Alford J; Anderson T; MacAskill M
    Eur Neurol; 2018; 79(3-4):206-210. PubMed ID: 29597229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective CERAD Neuropsychological Assessment in Patients With Multiple System Atrophy.
    Maass F; Hermann P; Varges D; Nuhn S; van Riesen C; Jamous A; Focke NK; Hewitt M; Leha A; Bähr M; Zerr I
    Front Neurol; 2022; 13():881369. PubMed ID: 35928131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.